| Keywords: |
leukemia; review; doxorubicin; interferon; cytarabine; methotrexate; neoplasms; animal; mice; cancer immunotherapy; melanoma; bone marrow; carcinoembryonic antigen; colonic neoplasms; cytotoxicity; cancer research; monoclonal antibody; antibodies, monoclonal; immunotherapy; antigens, neoplasm; immunoglobulin g; iodine 125; iodine 131; iodine radioisotopes; lymphoma; daunorubicin; vindesine; radioisotope; bone marrow transplantation; therapy; clinical trials; diphtheria toxin; pseudomonas exotoxin; immunization; survey; tumor cell destruction; growth substances; yttrium 90; astatine 211; bismuth 212; bromine 77; ricin; antibody-dependent cell cytotoxicity; cancer; human; fluorouridine; hematoporphyrin; support, non-u.s. gov't; support, u.s. gov't, p.h.s.; alpha amanitin; cobrotoxin; blood and hemopoietic system; boron 10; purothionin; scandium 47
|
